Enzo Biochem Inc (NYSE:ENZ) — Market Cap & Net Worth
Market Cap & Net Worth: Enzo Biochem Inc (ENZ)
Enzo Biochem Inc (NYSE:ENZ) has a market capitalization of $16.44 Million ($16.44 Million) as of September 16, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #25819 globally and #5426 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Enzo Biochem Inc's stock price $0.54 by its total outstanding shares 52402800 (52.40 Million). Also see ENZ asset base for a full breakdown of the balance sheet.
Enzo Biochem Inc Market Cap History: 2015 to 2025
Enzo Biochem Inc's market capitalization history from 2015 to 2025. Data shows change from $215.13 Million to $28.29 Million (-17.08% CAGR). Also see Enzo Biochem Inc cash flow conversion for how efficiently the company converts equity into cash flow.
Enzo Biochem Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Enzo Biochem Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check ENZ stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.17x
Enzo Biochem Inc's market cap is 1.17 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $215.13 Million | $97.60 Million | -$2.29 Million | 2.20x | N/A |
| 2016 | $331.77 Million | $102.77 Million | $45.29 Million | 3.23x | 7.33x |
| 2017 | $389.62 Million | $107.80 Million | -$2.50 Million | 3.61x | N/A |
| 2018 | $132.90 Million | $104.71 Million | -$10.32 Million | 1.27x | N/A |
| 2019 | $125.73 Million | $81.17 Million | -$98.78 Million | 1.55x | N/A |
| 2020 | $120.47 Million | $76.02 Million | -$33.89 Million | 1.58x | N/A |
| 2021 | $153.46 Million | $117.73 Million | $3.42 Million | 1.30x | 44.80x |
| 2022 | $68.36 Million | $107.07 Million | -$22.58 Million | 0.64x | N/A |
| 2023 | $66.45 Million | $31.06 Million | $20.29 Million | 2.14x | 3.28x |
| 2024 | $37.43 Million | $31.91 Million | -$26.08 Million | 1.17x | N/A |
Competitor Companies of ENZ by Market Capitalization
Companies near Enzo Biochem Inc in the global market cap rankings as of September 16, 2026. Review ENZ tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Enzo Biochem Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #88 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #161 globally with a market cap of $147.88 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #476 globally with a market cap of $56.70 Billion USD ( CN¥387.49 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #578 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $641.39 |
| #161 | Danaher Corporation | NYSE:DHR | $147.88 Billion | $209.36 |
| #476 | WuXi AppTec Co Ltd | SHG:603259 | $56.70 Billion | CN¥156.67 |
| #578 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $350.78 |
Enzo Biochem Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Enzo Biochem Inc's market cap moved from $215.13 Million to $ 28.29 Million, with a yearly change of -17.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $28.29 Million | -24.42% |
| 2024 | $37.43 Million | -43.67% |
| 2023 | $66.45 Million | -2.80% |
| 2022 | $68.36 Million | -55.45% |
| 2021 | $153.46 Million | +27.38% |
| 2020 | $120.47 Million | -4.18% |
| 2019 | $125.73 Million | -5.39% |
| 2018 | $132.90 Million | -65.89% |
| 2017 | $389.62 Million | +17.44% |
| 2016 | $331.77 Million | +54.22% |
| 2015 | $215.13 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Enzo Biochem Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.44 Million USD |
| MoneyControl | $16.44 Million USD |
| MarketWatch | $16.44 Million USD |
| marketcap.company | $16.44 Million USD |
| Reuters | $16.44 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Enzo Biochem Inc
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development pro… Read more